Stephen F. Betz
Chief Scientific Officer · 3 filings · Latest: Sep 1, 2026
Crinetics Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CRNX | Stephen F. Betz | Chief Scientific Officer | Mar 16, 2026 | Sale | $37.37 | 10,612 | $396.6K | 137,101 | |
CRNX | Stephen Betz | — | Mar 16, 2026 | Proposed Sale | $37.49 | 26,525 | $994.4K | — | |
CRNX | STEPHEN BETZ | — | Jun 12, 2025 | Proposed Sale | $32.33 | 97,483 | $3.2M | — | |
CRNX | Betz Stephen F. | — | Sep 10, 2024 | Proposed Sale | $51.50 | 1,035 | $53.3K | — | |
CRNX | Betz Stephen F. | — | Aug 26, 2024 | Proposed Sale | $53.19 | 3,000 | $159.6K | — |